Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies.
Migliore F, Pelliccia F, Autore C, Bertaglia E, Cecchi F, Curcio A, Bontempi L, Curnis A, De Filippo P, D'Onofrio A, Francia P, Maurizi N, Musumeci B, Proclemer A, Zorzi A, Corrado D. Migliore F, et al. Among authors: maurizi n. J Cardiovasc Med (Hagerstown). 2018 Nov;19(11):633-642. doi: 10.2459/JCM.0000000000000712. J Cardiovasc Med (Hagerstown). 2018. PMID: 30222664 Review.
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.
Maurizi N, Tanini I, Olivotto I, Amendola E, Limongelli G, Losi MA, Allocca G, Perego GB, Pieragnoli P, Ricciardi G, De Filippo P, Ferrari P, Quarta G, Viani S, Rapacciuolo A, Bongiorni MG, Cecchi F. Maurizi N, et al. Int J Cardiol. 2017 Mar 15;231:115-119. doi: 10.1016/j.ijcard.2016.12.187. Epub 2017 Jan 4. Int J Cardiol. 2017. PMID: 28073660
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.
Maurizi N, Passantino S, Spaziani G, Girolami F, Arretini A, Targetti M, Pollini I, Tomberli A, Pradella S, Calabri GB, Vinattieri V, Bertaccini B, Leone O, De Simone L, Rapezzi C, Marchionni N, Cecchi F, Favilli S, Olivotto I. Maurizi N, et al. JAMA Cardiol. 2018 Jun 1;3(6):520-525. doi: 10.1001/jamacardio.2018.0789. JAMA Cardiol. 2018. PMID: 29710196 Free PMC article.
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.
Ghiselli L, Marchi A, Fumagalli C, Maurizi N, Oddo A, Pieri F, Girolami F, Rowin E, Mazzarotto F, Cicoira M, Ribichini F, Arretini A, Targetti M, Passantino S, Cecchi F, Marchionni N, Maron M, Mori F, Olivotto I. Ghiselli L, et al. Among authors: maurizi n. Eur J Prev Cardiol. 2020 Nov;27(17):1821-1831. doi: 10.1177/2047487319886961. Epub 2019 Nov 7. Eur J Prev Cardiol. 2020. PMID: 31698967
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
Fumagalli C, De Filippo V, Zocchi C, Tassetti L, Marra MP, Brunetti G, Baritussio A, Cipriani A, Bauce B, Carrassa G, Maurizi N, Zampieri M, Calore C, De Lazzari M, Berteotti M, Pieragnoli P, Corrado D, Olivotto I. Fumagalli C, et al. Among authors: maurizi n. Int J Cardiol. 2022 Apr 15;353:62-67. doi: 10.1016/j.ijcard.2022.01.022. Epub 2022 Jan 12. Int J Cardiol. 2022. PMID: 35031346
55 results